|
Hey Mary!
A platelet drop is apparently pretty common with Revlimid. I found a summary of the study that resulted in its approval by the FDA for MDS and it indicates that 62% of patients had platelet drops and half had relatively severe platelet drops.
This resulted in the dosing being interrupted in a lot of cases. The average time between having to stop the drug and the patient recovering enough to start it again was 28 days.
Hope that helps.
Take care!
Greg
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at www.greghankins.com
|